Precipio: Rises as CEO outlines attempts to avoid dilution

Precipio

11/03/2019 17:00

** Cancer diagnostics company's shares  PRPO.O  up ~9.1 pct
at $0.16, stock on track to erase YTD losses
    ** Precipio CEO issued letter to shareholders outlining the
steps co is taking to regain Nasdaq listing compliance while
avoiding stock dilution
    ** Co is trying to avoid reverse stock split, or to minimize
split ratio 
    ** Actively exploring 10b5-1 trading plan, among other
options, to encourage management stock buying; CEO intends to
participate if a plan is made effective  urn:newsml:reuters.com:*:nGNX3hysqq
    ** Will also avoid going to market to raise capital
    ** Deadline for co to regain compliance with $1.00 minimum
bid price requirement of Nasdaq is March 25
    ** Up to Friday's close, stock had fallen ~6.2 pct YTD, but
has now gained ~5.8 pct YTD at today's session high 

 (Reporting by Aditi Sebastian in Bengaluru)
 ((Email: aditi.sebastian@thomsonreuters.com))